Literature DB >> 31385237

Analysis of VEGF gene polymorphisms and serum VEGF protein levels contribution in polycystic ovary syndrome of patients.

Lei Bao1,2,3, Rabbani Syed4, Mustafa Sawsan Aloahd5.   

Abstract

Vascular endothelial growth factor (VEGF) is a well-known factor in reproductive function and contributes to the pathogenesis of polycystic ovary syndrome (PCOS). Genetic variations in VEGFA gene were suggested to contribute alterations in VEGF secretion and PCOS. This study evaluated the association of VEGFA SNPs with altered VEGF secretion level and PCOS among ethnically-matched control women. This prospective case-control study was conducted from 2016 to 2018 and comprised of 55 women with PCOS and 52 control subjects. ELISA was used to measure VEGF levels; and various other related bio chemicals whereas the genotyping of VEGFA variants was performed through the analysis of nine SNPs of VEGF. PRL, E2, PRGE testosterone and glucose level were found to be insignificantly different. The levels of FSH, LH, LH/FSH, TT, insulin, SHBG and HOMA-IR were significantly higher in the study group. Among the nine tested variants of VEGF SNPs, two SNPs rs3025020 and rs833061, consisted of TT (Recessive and Dominant homozygous, respectively) which were marginally higher in test. The SNP rs1570360 had significantly higher GG allele (32.73%) which was recessive homozygous. There was no significant difference observed in genotype frequencies related to higher value of VEGF. The genotype frequencies for the studied SNPs were in alignment with Hardy-Weinberg equilibrium (HWE). The mean serum VEGF levels got significantly increased in PCOS group. No significant association was found between VEGF genotypes and its serum levels. VEGF levels in rs699947 (AA-major homozygous), rs3025039 (CC-major homozygous) and rs833061 (TT & CC-major & minor homozygous) genotypes were significantly higher in PCOS. The study results evidently proved that the allelic variants in genes may be a factor for PCOS and VEGF serum levels with respect to few SNP variants only. These findings indicated that VEGF may be involved in PCOS status and confirmed the previous association between genetic variants in VEGF, serum level of VEGF protein and PCOS.

Entities:  

Keywords:  Polycystic ovary syndrome (PCOS) genetic variation; Serum VEGF levels; Single nucleotide polymorphism; Vascular endothelial growth factor (VEGF)

Mesh:

Substances:

Year:  2019        PMID: 31385237     DOI: 10.1007/s11033-019-05015-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  33 in total

1.  Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome.

Authors:  William W Hurd; Mohamed Y Abdel-Rahman; Salah A Ismail; Mostafa A Abdellah; Christine L Schmotzer; Ajay Sood
Journal:  Fertil Steril       Date:  2011-08-03       Impact factor: 7.329

2.  Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance.

Authors:  Victor M Victor; Milagros Rocha; Celia Bañuls; Maria Sanchez-Serrano; Eva Sola; Marcelino Gomez; Antonio Hernandez-Mijares
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

Review 3.  The role of genes in the polycystic ovary syndrome: predisposition and mechanisms.

Authors:  Eythimios Deligeoroglou; Christina Kouskouti; Panagiotis Christopoulos
Journal:  Gynecol Endocrinol       Date:  2009-09       Impact factor: 2.260

Review 4.  Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome.

Authors:  Enrico Carmina
Journal:  Front Horm Res       Date:  2012-10-18       Impact factor: 2.606

Review 5.  Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review.

Authors:  Panagiotis Peitsidis; Rina Agrawal
Journal:  Reprod Biomed Online       Date:  2010-01-14       Impact factor: 3.828

6.  Haplotyping strategy highlights the specificity of FTO gene association with polycystic ovary syndrome in Tunisian women population.

Authors:  Assila Ben Salem; Redha Attaoua; Nabil Mtiraoui; Sawssen Meddeb; Olfa Kacem; Mounir Ajina; Moncef Souissi; Patrick Poucheret; Christophe Normand; Touhami Mahjoub; Florin Grigorescu
Journal:  Gene       Date:  2014-12-12       Impact factor: 3.688

Review 7.  Role of vascular endothelial growth factor in ovarian physiology - an overview.

Authors:  Monika M Kaczmarek; Dieter Schams; Adam J Ziecik
Journal:  Reprod Biol       Date:  2005-07       Impact factor: 2.376

8.  Color Doppler sonographic analysis of uterine and ovarian artery blood flow in women with polycystic ovary syndrome.

Authors:  Sebiha Ozkan; Birol Vural; Eray Calişkan; Harika Bodur; Erkan Türköz; Füsun Vural
Journal:  J Clin Ultrasound       Date:  2007 Jul-Aug       Impact factor: 0.910

9.  Evaluation of the relationship between gestational diabetes and a history of polycystic ovarian syndrome.

Authors:  Maryam Kashanian; Zohreh Fazy; Arezoo Pirak
Journal:  Diabetes Res Clin Pract       Date:  2008-02-21       Impact factor: 5.602

10.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

View more
  6 in total

Review 1.  Polymorphisms of vascular endothelial growth factor and recurrent implantation failure: a systematic review and meta-analysis.

Authors:  Hong Zeng; Lian Hu; Hebin Xie; Wenmin Ma; Song Quan
Journal:  Arch Gynecol Obstet       Date:  2021-04-23       Impact factor: 2.344

2.  Polymorphisms rs2010963 and rs833061 of the VEGF gene in polycystic ovary syndrome.

Authors:  Anna Luiza Silva Almeida Vicente; Alessandra Bernadete Trovó de Marqui; Mariana Kefalas Oliveira Gomes; Alan Vinicius Assunção-Luiz; Marly Aparecida Spadotto Balarin; Sarah Cristina Sato Vaz Tanaka; Elisabete Aparecida Mantovani Rodrigues de Resende; Marco Fábio Prata Lima; Mariangela Torreglosa Ruiz Cintra
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-06-24       Impact factor: 1.712

Review 3.  Association of vascular endothelial growth factor polymorphisms with polycystic ovarian syndrome risk: a meta-analysis.

Authors:  Jiahui Zhao; Da Li; Huaiyun Tang; Lisha Tang
Journal:  Reprod Biol Endocrinol       Date:  2020-03-09       Impact factor: 5.211

4.  Variations in the Profiles of Vascular-Related Factors Among Different Sub-Types of Polycystic Ovarian Syndrome in Northern China.

Authors:  Mei-Mei Liu; Xiu-Hui Chen; Xiu-Min Lu; Fang-Fang Wang; Chao Wang; Yu Liu; Pei-Ling Li; Bo-Tao Du; Sha Liang; Pi-Dong Gong; Yu-Xin Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-26       Impact factor: 5.555

Review 5.  A Narrative Review of Current Understanding of the Pathophysiology of Polycystic Ovary Syndrome: Focus on Plausible Relevance of Vitamin D.

Authors:  Rajeshwari Kalyanaraman; Lubna Pal
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

6.  microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index.

Authors:  Alexandra E Butler; Vimal Ramachandran; Thozhukat Sathyapalan; Rhiannon David; Nigel J Gooderham; Manasi Benurwar; Soha R Dargham; Shahina Hayat; S Hani Najafi-Shoushtari; Stephen L Atkin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-28       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.